ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 183

Musculoskeletal Ultrasound Reveals Calcific Deposition Arthropathy in Seronegative Inflammatory Arthritis Patients

Sheila L. Arvikar1, Janice Lin2 and Minna J. Kohler3, 1Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston, MA, 2Dermatology, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Allergy, and Immunology, Massachusetts General Hospital / Harvard Medical School, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Calcium pyrophosphate dihydrate (CPPD), Crystal-induced arthritis, inflammatory arthritis, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Metabolic and Crystal Arthropathies: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose

Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) have vastly improved the diagnosis of rheumatoid arthritis (RA), but the diagnosis and management of seronegative RA patients remains a challenge. Musculoskeletal ultrasound (US) can improve the diagnosis of synovitis, and also reveal crystalline deposition potentially contributing to arthritis in a subset of patients.

Methods

We retrospectively reviewed clinical and US characteristics of 26 consecutive seronegative RA patients found to have crystalline deposits by US performed by 1 US-trained rheumatologist over 1 year. Images from 7 age-matched disease controls (4 osteoarthritis (OA), 2 seropositive RA, and 1 seronegative RA) were also reviewed. All images were reviewed by a 2nd rheumatologist.

Results

Typical of RA cohorts, the 26 patients were predominantly female (62%), with a median age of 57. RF and ACPA were by definition negative.  Median levels of inflammatory markers were in normal ranges. 62% of the patients met 2010 ACR/EULAR classification criteria for RA. Median symptom duration was 1.4 years, and only 5 patients were receiving disease-modifying antirheumatic drugs (DMARDs) at the time of US. Metacarpophalangeal (MCP) joints were most commonly symptomatic (65%). By X-ray, only 2 patients had chondrocalcinosis, and 1 had erosion.

There was 100% inter-reader agreement of the US images, encompassing 7 anatomic sites (shoulder, elbow, wrist, hand, knee, ankle, and foot). Images in all 26 patients revealed multiple hyperechoic densities consistent with the US appearance of calcium pyrophosphate dihydrate (CPPD) vs. calcium hydroxyapatite crystals, and were not typical of gout. Calcific deposits, in all cases associated with synovitis, were identified in joints, tendons, and/or tendon sheaths. By comparison, control imaging demonstrated few scattered calcifications without synovitis in only 1 OA patient.

Nearly all 26 patients (90%) had calcifications in both joints and tendons. Calcification pattern in joints was most commonly round (79%), followed by punctate (45%), whereas calcification pattern in tendons was more frequently punctate (79%) followed by linear (42%). Over half (58%) of patients had all 3 patterns. Nine (35%) patients had US evidence of bony erosions. There were no effusions amenable to aspiration. Subsequent testing of 10 patients revealed elevated parathyroid hormone levels in 4 patients, a risk factor for CPPD.

Conclusion

Our findings of hyperechoic deposits associated with synovitis on US suggests that crystalline disease, such as CPPD arthropathy, may be an explanation for arthritis in a subset of seronegative RA patients. Although microscopic analysis is the gold standard in diagnosis of crystalline arthropathy, US may be valuable, particularly when X-rays are unrevealing and effusions amenable to aspiration are lacking. Detection of crystals may reveal abnormalities such as hyperparathyroidism, and may affect treatment strategies. Studies with synovial tissue or fluid crystal analysis prospectively evaluating the prevalence of crystal deposition are needed to evaluate the role for US in the screening of seronegative RA patients.


Disclosure:

S. L. Arvikar,

Arthritis Foundation,

2;

J. Lin,
None;

M. J. Kohler,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-ultrasound-reveals-calcific-deposition-arthropathy-in-seronegative-inflammatory-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology